A new draft of the 21st Century Cures Act recommends additional funding for the US National Institutes of Health.
Luke Timmerman at Forbes speaks with Illumina's Jay Flatley about the DNA sequencing market.
In Nature this week: improved genome inference using population reference graph, and more.
While personalized medicine may show promise for treating patients, the cost of such treatments is a concern, the New York Times writes.
Corporate wellness programs may soon include genetic testing, the AP reports.
Protein & Cell says it published the human germline editing paper as a "sounding of an alarm."
In Genome Research this week: exome sequencing of mouse disease model strains, high-quality genomes of Saccharomyces cerevisiae strains, and more.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.
A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.
Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.
An Australian study of personalized medicine has run into problems as it recruits patients.
The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.
The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.
In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.
Many researchers call the work by Chinese scientists, who used the gene editing technology on human germlines, unethical, among other things.
At Technology Review, University of California,Berkeley's Jennifer Doudna discusses the power, and possible perils, of genome editing.
Researchers say there's a genetic component behind why mosquitoes seem to like some people more than others.
In Nature this week: draft genomes of cultivated Upland cotton, and more.
In a New York Times op-ed, Eric Lander argues that forensic science needs to be of high quality.
Newt Gingrich calls for a doubling of the National Institutes of Health budget.
Color Genomics, a low-cost breast cancer genetic testing company, enters the fray, while others band together to work out the meaning of variants of unknown significance.